The coagulation markers market size has grown strongly in recent years. It will grow from $1.24 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising incidence of thrombotic disorders, increasing prevalence of cardiovascular diseases, growing use of d-dimer testing in clinical practice, expansion of hospital diagnostic laboratories, improved awareness of coagulation-related complications.
The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population with higher clotting risk, increasing demand for rapid diagnostic decision-making, expansion of emergency and trauma care services, growing focus on preventive thrombotic risk assessment, rising adoption of advanced coagulation testing technologies. Major trends in the forecast period include rising demand for early and accurate thrombosis detection, increasing use of coagulation markers in emergency and critical care, growing adoption of rapid and point-of-care coagulation testing, expansion of coagulation marker testing in trauma and surgical settings, increasing integration of coagulation testing in routine diagnostics.
The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.
Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.
Major companies operating in the coagulation markers market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc.
North America was the largest region in the coagulation markers market in 2025. The regions covered in the coagulation markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coagulation markers market by increasing costs for imported reagents, assay kits, antibodies, and laboratory consumables used in d-dimer and fibrinogen testing. These cost pressures have particularly affected immunoassay-based and automated testing segments, with asia-pacific and europe facing greater exposure due to global reagent supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic laboratories and influenced test pricing. However, tariffs have also encouraged local reagent manufacturing, alternative sourcing, and regional production expansion, supporting long-term supply chain stability.
The coagulation markers market research report is one of a series of new reports that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.
The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.
The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population with higher clotting risk, increasing demand for rapid diagnostic decision-making, expansion of emergency and trauma care services, growing focus on preventive thrombotic risk assessment, rising adoption of advanced coagulation testing technologies. Major trends in the forecast period include rising demand for early and accurate thrombosis detection, increasing use of coagulation markers in emergency and critical care, growing adoption of rapid and point-of-care coagulation testing, expansion of coagulation marker testing in trauma and surgical settings, increasing integration of coagulation testing in routine diagnostics.
The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.
Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.
In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.
Major companies operating in the coagulation markers market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc.
North America was the largest region in the coagulation markers market in 2025. The regions covered in the coagulation markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the coagulation markers market by increasing costs for imported reagents, assay kits, antibodies, and laboratory consumables used in d-dimer and fibrinogen testing. These cost pressures have particularly affected immunoassay-based and automated testing segments, with asia-pacific and europe facing greater exposure due to global reagent supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic laboratories and influenced test pricing. However, tariffs have also encouraged local reagent manufacturing, alternative sourcing, and regional production expansion, supporting long-term supply chain stability.
The coagulation markers market research report is one of a series of new reports that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.
The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.
The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Coagulation Markers Market Characteristics
3. Coagulation Markers Market Supply Chain Analysis
4. Global Coagulation Markers Market Trends and Strategies
5. Coagulation Markers Market Analysis of End Use Industries
7. Global Coagulation Markers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Coagulation Markers Total Addressable Market (TAM) Analysis for the Market
9. Coagulation Markers Market Segmentation
10. Coagulation Markers Market Regional and Country Analysis
11. Asia-Pacific Coagulation Markers Market
12. China Coagulation Markers Market
13. India Coagulation Markers Market
14. Japan Coagulation Markers Market
15. Australia Coagulation Markers Market
16. Indonesia Coagulation Markers Market
17. South Korea Coagulation Markers Market
18. Taiwan Coagulation Markers Market
19. South East Asia Coagulation Markers Market
20. Western Europe Coagulation Markers Market
21. UK Coagulation Markers Market
22. Germany Coagulation Markers Market
23. France Coagulation Markers Market
24. Italy Coagulation Markers Market
25. Spain Coagulation Markers Market
26. Eastern Europe Coagulation Markers Market
27. Russia Coagulation Markers Market
28. North America Coagulation Markers Market
29. USA Coagulation Markers Market
30. Canada Coagulation Markers Market
31. South America Coagulation Markers Market
32. Brazil Coagulation Markers Market
33. Middle East Coagulation Markers Market
34. Africa Coagulation Markers Market
36. Coagulation Markers Market Competitive Landscape and Company Profiles
37. Coagulation Markers Market Other Major and Innovative Companies
40. Coagulation Markers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Coagulation Markers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses coagulation markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for coagulation markers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation markers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: D-Dimer Assay; Fibrinogen Assay2) By Sample Type: Plasma; Whole Blood Sample; Other Sample Types
3) By Technology: Fluorescence Immunoassay; Enzyme-Linked Immuno Sorbent Assay (ELISA); Rapid Test; Particle Enhanced Immunoturbidimetric Assay
4) By Application: Deep Venous Thrombosis (DVT); Pulmonary Embolism (PE); Disseminated Intravascular Coagulation (DIC); Trauma; Other Applications
5) By End User: Hospital; Specialty Clinics; Academic And Research Institute; Diagnostics Laboratories
Subsegments:
1) By D-Dimer Assay: ELISA-Based D-Dimer Assay; Lateral Flow Immunoassay D-Dimer Test; Chemiluminescent Immunoassay D-Dimer Test2) By Fibrinogen Assay: Clauss Fibrinogen Assay; Functional Fibrinogen Assay; Automated Fibrinogen Assay
Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; W L Gore & Associates Inc; Lepu Medical Technology Beijing Co Ltd; MicroPort Scientific Corporation; Berlin Heart GmbH; Syncardia Systems LLC; Occlutech Holding AG; Sahajanand Medical Technologies Pvt Ltd; Xeltis AG; Procyrion Inc; Heartstitch Inc; Cardia Inc; OSYPKA Medical GmbH; On-X Life Technologies Inc; Ventracor Limited; HemoFlow Technologies; NuPulseCV Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Coagulation Markers market report include:- Johnson & Johnson
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- W L Gore & Associates Inc
- Lepu Medical Technology Beijing Co Ltd
- MicroPort Scientific Corporation
- Berlin Heart GmbH
- Syncardia Systems LLC
- Occlutech Holding AG
- Sahajanand Medical Technologies Pvt Ltd
- Xeltis AG
- Procyrion Inc
- Heartstitch Inc
- Cardia Inc
- OSYPKA Medical GmbH
- On-X Life Technologies Inc
- Ventracor Limited
- HemoFlow Technologies
- NuPulseCV Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.32 Billion |
| Forecasted Market Value ( USD | $ 1.67 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
